CDKN2A and diffuse large B-cell lymphoma: The proliferative nature of RT-DLBCL may in part be explained by deletions in CDKN2A (seen in 20% of RT-DLBCL cases) [31], which allows for progression through the cell cycle and uncontrolled replication of neoplastic cells.